About Canzatax 260mg Injection
Canzatax 260mg Injection offers an affordable and brilliant solution for cancer treatment, harnessing the power of the uncommon taxane derivative-docetaxel. Crafted for intravenous infusion, this 260mg/43.4mL single-dose vial delivers unbeatable efficacy against breast, lung, prostate, head and neck, and gastric cancers. A clear, ephemeral, colorless to pale yellow viscous solution, Canzatax combines docetaxel, polysorbate 80, ethanol, and water for injection. This antineoplastic agent is prescription-only, cytotoxic, and stored below 25C. Jump on this advanced therapeutic for reliable oncology care, tailored for medical professionals and health suppliers across India.
Usage & Applications: Broad Oncology Benefits
Canzatax 260mg Injection is predominantly used in the treatment of multiple cancers, including breast, non-small cell lung, prostate, head and neck, and gastric cancers. This premium cytotoxic agent is administered intravenously by healthcare professionals in hospitals, clinics, and oncology centers. Its application extends to both initial and progressive stages of cancer, making it invaluable for oncologists and medical specialists seeking effective antineoplastic therapy for their patients.
Packaging Details and Reliable Supply
Packing & Dispatch of Canzatax 260mg Injection are carried out with utmost care, ensuring goods transport is safe and premium quality is maintained. Each vial is securely packaged to protect from light and temperature fluctuations, preserving product efficacy. With a consistent supply ability, the product ships through reputed FOB Ports across India, allowing timely and efficient distribution to hospitals, pharmacies, and medical suppliers nationwide.
FAQ's of Canzatax 260mg Injection:
Q: How should Canzatax 260mg Injection be stored to maintain its efficacy?
A: Canzatax 260mg Injection should be stored below 25C, protected from direct light, and must not be frozen. Strict adherence to these conditions helps preserve the solution's effectiveness and shelf life.
Q: What types of cancer can be treated with Canzatax 260mg Injection?
A: This injection is indicated for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, head and neck cancer, as well as gastric cancer, providing a comprehensive antineoplastic therapy for various oncology needs.
Q: Who can administer Canzatax 260mg Injection?
A: Administration of Canzatax is limited to healthcare professionals trained in intravenous infusion procedures, typically within hospital or clinic settings. Self-administration is not recommended due to its cytotoxic nature.
Q: What are the contraindications for using Canzatax 260mg Injection?
A: Canzatax 260mg Injection is contraindicated in patients hypersensitive to docetaxel or its formulation components and in those with a neutrophil count less than 1500/mm3.
Q: When is Canzatax 260mg Injection prescribed?
A: Canzatax 260mg Injection is prescribed only under medical supervision after evaluating the patient's diagnosis and blood counts, as it is a cytotoxic, prescription-only medication for specific cancer types.
Q: What is the dosage form and composition of Canzatax 260mg Injection?
A: Canzatax comes as a single-use vial containing a clear, colorless to pale yellow viscous solution of docetaxel (260mg), along with polysorbate 80, ethanol, and water for injection.